Literature DB >> 18285499

Pseudomonas aeruginosa cystic fibrosis isolates from individual patients demonstrate a range of levels of lethality in two Drosophila melanogaster infection models.

Erika I Lutter1, Monica M P Faria, Harvey R Rabin, Douglas G Storey.   

Abstract

Recently, two Drosophila melanogaster models of infection, fly feeding and fly nicking, have been developed that allow a determination of pathogenic potential of Pseudomonas aeruginosa isolates. In this study, control strains, isolates from burn wounds, and isolates from the sputa of cystic fibrosis (CF) patients were used to compare the two infection models to determine whether any of the isolates might be better adapted to either of the models. In addition, our goal was to determine the variability of isolates from individual CF patients. Three of four control strains (PAO1, PAK, and PA14) caused significant mortality in the flies in both models of infection. The remaining control strain, PA103, was lethal to flies in the nicking model but lacked significant lethality in the feeding model. The burn wound isolates had a high level of lethality in both models. Interestingly, the CF isolates had the largest diversity of lethality in both models of infection. The range of pathogenic potentials of the CF isolates occurred across a cohort of patients, both at the patient level and down to the level of individual sputum samples. The majority of all isolates had similar levels of lethality in both fly infection models. However, two CF isolates were significantly more lethal in the nicking model, and three CF isolates were significantly more lethal in the feeding model. In conclusion, the two Drosophila infection models were useful for the analysis of the diversity of pathogenic potentials of P. aeruginosa isolates.

Entities:  

Mesh:

Year:  2008        PMID: 18285499      PMCID: PMC2346680          DOI: 10.1128/IAI.01165-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  KatA, the major catalase, is critical for osmoprotection and virulence in Pseudomonas aeruginosa PA14.

Authors:  Ji-Sun Lee; Yun-Jeong Heo; Jeong K Lee; You-Hee Cho
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.

Authors:  Prabhakar Salunkhe; Catherine H M Smart; J Alun W Morgan; Stavroula Panagea; Martin J Walshaw; C Anthony Hart; Robert Geffers; Burkhard Tümmler; Craig Winstanley
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

4.  The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.

Authors:  Robert K Ernst; Kristin N Adams; Samuel M Moskowitz; Gretchen M Kraig; Kiyoshi Kawasaki; Christopher M Stead; M Stephen Trent; Samuel I Miller
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

5.  Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; B Boxerbaum; R C Stern; P J Kuchenbrod
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

6.  Drosophila host defense after oral infection by an entomopathogenic Pseudomonas species.

Authors:  Nicolas Vodovar; Marisa Vinals; Peter Liehl; Alan Basset; Jeril Degrouard; Paul Spellman; Frédéric Boccard; Bruno Lemaitre
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

7.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression.

Authors:  M J Gambello; B H Iglewski
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

9.  Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.

Authors:  J Lam; R Chan; K Lam; J W Costerton
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Association between transcript levels of the Pseudomonas aeruginosa regA, regB, and toxA genes in sputa of cystic fibrosis patients.

Authors:  T L Raivio; E E Ujack; H R Rabin; D G Storey
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.609

View more
  14 in total

1.  Differential expression of the major catalase, KatA in the two wild type Pseudomonas aeruginosa strains, PAO1 and PA14.

Authors:  Bi-O Kim; In-Young Chung; You-Hee Cho
Journal:  J Microbiol       Date:  2019-06-11       Impact factor: 3.422

2.  The genetic basis for variation in resistance to infection in the Drosophila melanogaster genetic reference panel.

Authors:  Jonathan B Wang; Hsiao-Ling Lu; Raymond J St Leger
Journal:  PLoS Pathog       Date:  2017-03-03       Impact factor: 6.823

3.  Translocation of Pseudomonas aeruginosa from the intestinal tract is mediated by the binding of ExoS to an Na,K-ATPase regulator, FXYD3.

Authors:  Jun Okuda; Naoki Hayashi; Masashi Okamoto; Shinji Sawada; Shu Minagawa; Yoshitaka Yano; Naomasa Gotoh
Journal:  Infect Immun       Date:  2010-08-30       Impact factor: 3.441

4.  Drosophila melanogaster as a model host for the Burkholderia cepacia complex.

Authors:  Josée Castonguay-Vanier; Ludovic Vial; Julien Tremblay; Eric Déziel
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

5.  Lethality and developmental delay in Drosophila melanogaster larvae after ingestion of selected Pseudomonas fluorescens strains.

Authors:  Marika H Olcott; Marcella D Henkels; Kise L Rosen; Francesca L Walker; Baruch Sneh; Joyce E Loper; Barbara J Taylor
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

Review 6.  Hospital infections, animal models and alternatives.

Authors:  R Seabra; N Bhogal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-12-19       Impact factor: 3.267

7.  Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos.

Authors:  Mark K Brannon; J Muse Davis; Jonathan R Mathias; Chris J Hall; Julia C Emerson; Philip S Crosier; Anna Huttenlocher; Lalita Ramakrishnan; Samuel M Moskowitz
Journal:  Cell Microbiol       Date:  2009-01-15       Impact factor: 3.715

8.  Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection.

Authors:  Yiorgos Apidianakis; Laurence G Rahme
Journal:  Nat Protoc       Date:  2009-08-13       Impact factor: 13.491

9.  Drosophila melanogaster as an animal model for the study of Pseudomonas aeruginosa biofilm infections in vivo.

Authors:  Heidi Mulcahy; Christopher D Sibley; Michael G Surette; Shawn Lewenza
Journal:  PLoS Pathog       Date:  2011-10-06       Impact factor: 6.823

Review 10.  Deconstructing host-pathogen interactions in Drosophila.

Authors:  Ethan Bier; Annabel Guichard
Journal:  Dis Model Mech       Date:  2011-10-06       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.